Arvind Remedies commissions Irungattukottai unit Illustrative image – not actual.

Arvind Remedies, a Chennai-based pharmaceuticals company, has commissioned its drug manufacturing unit at Irungattukottai, near Chennai, Tamil Nadu, to tap the US market.

 

The company has recently started testing and developing analgesic and cardiac generic drugs (tablets) at the plant. It has invested Rs 250 crore in the project. It will seek USFDA approval in six months. After receiving USFDA clearance, the company will seek approvals in the UK, Europe and Australia, too. Since these approvals could take two to three years, Arvind Remedies plans to use the plant for its existing markets.

 

The company has set up a subsidiary in New Jersey to take care of its US strategy. It also plans to get into a manufacturing contract for other American pharma companies.

 

Arvind Remedies has manufacturing facilities at Kakkalur in Chennai and at Roorkee in Uttarakhand, for allopathic and ayurvedic formulations. These are supplied to the domestic market through government hospitals and retail outlets and exported to Asia, Africa and CIS.

← All latest storiesBack to top →